findmyKOL

Alicia Rodriguez-Pla, MD, PhD, MPH

Basic profile

California State University, Fresno

ORCIDNPI
RegionFresno, CA · WestSpecialtyRheumatologyFocusRheumatology/Immunology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Alicia Rodriguez-Pla is a Rheumatology/Immunology physician affiliated with California State University, Fresno. OpenAlex indexes 36 publications with 609 citations (h-index 13).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
36publications

Distinct works indexed by OpenAlex, matched via ORCID.

609citations

Total citations across indexed works.

13h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
9companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Industry payments

9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

9 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cancer & immunology

    39.9%
    TNF inhibitor17.1%
    Enbrel Sureclick56%Humira(Cf)19%Humira Pen15%Enbrel10%
    Part D<11 patients
    Folate Analog Metabolic Inhibitor14%
    Methotrexate100%
    Part D29 patients

    + 2 more classes in this area

  • Antiparasitic

    18.8%
    Antimalarial18.8%
    Hydroxychloroquine Sulfate100%
    Part D39 patients
  • Nervous system

    16%
    SNRI7.8%
    Duloxetine Hcl100%
    Part D27 patients
    Gabapentinoids6.6%
    Gabapentin100%
    Part D25 patients

    + 1 more class in this area

Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”